Author Correction: Structural basis for partial agonism in 5-HT3A receptors

被引：0
作者：
Kevin Felt
Madeleine Stauffer
Leslie Salas-Estrada
Peter R. Guzzo
Dejian Xie
Jinkun Huang
Marta Filizola
Sudha Chakrapani
机构：
[1] Case Western Reserve University,Department of Physiology and Biophysics
[2] Icahn School of Medicine at Mount Sinai,Department of Pharmacological Sciences
[3] SciMount Therapeutics (Shenzhen) Co. Ltd.,Department of Pharmacology, School of Medicine
[4] Case Western Reserve University,Cleveland Center for Membrane and Structural Biology
[5] Case Western Reserve University,undefined
来源：
Nature Structural & Molecular Biology | 2024年 / 31卷 / 4期
关键词：
D O I：
10.1038/s41594-024-01306-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：728 / 728
相关论文
共 50 条
  • [31] Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization
    Xiong, Wei
    Hosoi, Masako
    Koo, Bon-Nyeo
    Zhang, Li
    MOLECULAR PHARMACOLOGY, 2008, 73 (02) : 314 - 322
  • [32] Isolation of a partial cDNA clone of the porcine 5-HT3A receptor subunit
    Fletcher, S
    Hope, AG
    Franklin, FCH
    Barnes, NM
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U71 - U71
  • [33] Interactions of metoclopramide and ergotamine with human 5-HT3A receptors and human 5-HT reuptake carriers
    Walkembach, J
    Brüss, M
    Urban, BW
    Barann, M
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (04) : 543 - 552
  • [34] Author Correction: Structural basis of ketamine action on human NMDA receptors
    Youyi Zhang
    Fei Ye
    Tongtong Zhang
    Shiyun Lv
    Liping Zhou
    Daohai Du
    He Lin
    Fei Guo
    Cheng Luo
    Shujia Zhu
    Nature, 2021, 598 : E3 - E3
  • [35] VUF10166, a Novel Compound with Differing Activities at 5-HT3A and 5-HT3AB Receptors
    Thompson, A. J.
    Verheij, M. H. P.
    de Esch, I. J. P.
    Lummis, S. C. R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 341 (02) : 350 - 359
  • [36] The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors
    Thompson, Andrew J.
    Verheij, Mark H. P.
    Verbeek, Joost
    Windhorst, Albert D.
    de Esch, Iwan J. P.
    Lummis, Sarah C. R.
    NEUROPHARMACOLOGY, 2014, 86 : 378 - 388
  • [37] Agonists and antagonists induce different palonosetron dissociation rates in 5-HT3A and 5-HT3AB receptors
    Lummis, Sarah C. R.
    Thompson, Andrew J.
    NEUROPHARMACOLOGY, 2013, 73 : 241 - 246
  • [38] Role of leucine 293 in alcohol modulatory actions on 5-HT3A receptors.
    Hu, XQ
    Machu, T
    Lovinger, D
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (05) : 60A - 60A
  • [39] Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors
    McLoughlin, DJ
    Strange, PG
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) : 347 - 357
  • [40] The effects of fentanyl-like Opioids and hydromorphone on human 5-HT3A receptors
    Wittmann, Maria
    Schaaf, Thomas
    Peters, Ineke
    Wirz, Stefan
    Urban, Bernd W.
    Barann, Martin
    ANESTHESIA AND ANALGESIA, 2008, 107 (01) : 107 - 112
12345